(S (PP (IN Unlike) (NP (NP (JJ common) (NNS cancers)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT those)) (PP (IN of) (NP (DT the) (NN prostate) (CC and) (NN breast))))))) (, ,) (NP (NP (NN tumor) (NN grading)) (PP (IN in) (NP (JJ rare) (NNS cancers)))) (VP (VBZ is) (ADJP (ADJP (JJ difficult)) (CC and) (ADJP (RB largely) (JJ undefined))) (PP (IN because) (IN of) (NP (NP (JJ small) (NN sample) (NNS sizes)) (, ,) (NP (NP (DT the) (NN sheer) (NN volume)) (PP (IN of) (NP (NN time))) (VP (VBN needed) (S (VP (TO to) (VP (VB undertake) (PP (IN on) (NP (PDT such) (DT a) (NN task)))))))) (, ,) (CC and) (NP (NP (DT the) (JJ inherent) (NN difficulty)) (PP (IN of) (S (VP (VBG extracting) (NP (JJ human-observed) (NNS patterns))))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ challenging)) (NNS examples)))) (VP (VBZ is) (NP (NP (JJ intrahepatic) (NN cholangiocarcinoma)) (PRN (-LRB- -LRB-) (NP (NNP ICC)) (-RRB- -RRB-)) (, ,) (NP (NP (DT a) (JJ primary) (NN liver) (NN cancer)) (VP (VBG arising) (PP (IN from) (NP (DT the) (JJ biliary) (NN system))))) (, ,) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ well-recognized) (NN tumor) (NN heterogeneity)) (CC and) (NP (NP (DT no) (VBG grading) (NN paradigm)) (CC or) (NP (JJ prognostic) (NNS biomarkers))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ new) (JJ unsupervised) (JJ deep) (JJ convolutional) (JJ autoencoder-based) (NN clustering) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (NNS groups) (ADVP (RB together)) (NP (NP (ADJP (JJ cellular) (CC and) (JJ structural)) (NNS morphologies)) (PP (IN of) (NP (NN tumor)))) (PP (IN in) (NP (CD 246) (NNP ICC) (VBD digitized) (JJ whole) (NNS slides))) (, ,) (PP (VBN based) (PP (IN on) (NP (JJ visual) (NN similarity))))))))) (. .))
(S (PP (IN From) (NP (NP (DT this) (JJ visual) (NN dictionary)) (PP (IN of) (NP (NN histologic) (NNS patterns))))) (, ,) (NP (PRP we)) (VP (VBP use) (NP (DT the) (NNS clusters)) (PP (IN as) (NP (NP (NNS covariates)) (SBAR (S (VP (TO to) (VP (VB train) (NP (JJ Cox-proportional) (NN hazard) (NN survival) (NNS models))))))))) (. .))
(S (PP (IN In) (NP (JJ univariate) (NN analysis))) (, ,) (NP (CD three) (NNS clusters)) (VP (VBD were) (VP (ADVP (RB significantly)) (VBN associated) (PP (IN with) (NP (JJ recurrence-free) (NN survival))))) (. .))
(S (NP (NP (NNS Combinations)) (PP (IN of) (NP (DT these) (NNS clusters)))) (VP (VBD were) (ADJP (JJ significant)) (PP (IN in) (NP (JJ multivariate) (NN analysis)))) (. .))
(S (S (PP (IN In) (NP (NP (DT a) (JJ multivariate) (NN analysis)) (PP (IN of) (NP (DT all) (NNS clusters))))) (, ,) (NP (CD five)) (VP (VBD showed) (NP (NP (NN significance)) (PP (TO to) (NP (JJ recurrence-free) (NN survival)))))) (, ,) (S (ADVP (RB however)) (NP (DT the) (JJ overall) (NN model)) (VP (VBD was) (RB not) (VP (VBN measured) (S (VP (TO to) (VP (VB be) (ADJP (JJ significant)))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (DT a) (NN pathologist)) (VP (VP (VBN assigned) (NP (JJ clinical) (NN terminology)) (PP (TO to) (NP (NP (DT the) (JJ significant) (NNS clusters)) (PP (IN in) (NP (DT the) (JJ visual) (NN dictionary)))))) (CC and) (VP (VBD found) (NP (NP (NN evidence)) (VP (VBG supporting) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (JJ collagen-enriched) (NN fibrosis)) (VP (VBZ plays) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (NN disease) (NN severity)))))))))))) (. .))
(S (NP (DT These) (NNS results)) (VP (VP (VBP offer) (NP (NP (JJ insight)) (PP (IN into) (NP (NP (DT the) (NN future)) (PP (IN of) (NP (NN cancer) (NN subtyping))))))) (CC and) (VP (NN show) (SBAR (IN that) (S (NP (JJ computational) (NN pathology)) (VP (MD can) (VP (VB contribute) (PP (TO to) (NP (VB disease) (NN prognostication))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (JJ rare) (NNS cancers))))))))) (. .))
